P435 HER2/neu-derived peptide conjugated to liposomes containing DOPE as an effective prophylactic vaccine formulation for breast cancer

Nanoliposomes as the adjuvant delivery systems in cancer immunotherapy

(2018) Parvin Zamani et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer

(2017) Nastaran Barati et al.   IMMUNOLOGY LETTERS

Improved tumor accumulation and therapeutic efficacy of CTLA-4-blocking antibody using liposome-encapsulated antibody: In vitro and in vivo studies

(2017) Amin Reza Nikpoor et al.   Nanomedicine-Nanotechnology Biology and Medicine

Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids

(2017) Mona Yazdani et al.   Current Drug Delivery

Poly (I:C)-DOTAP cationic nanoliposome containing multi-epitope HER2-derived peptide promotes vaccine-elicited anti-tumor immunity in a murine model

(2016) Ghazal Alipour Talesh et al.   IMMUNOLOGY LETTERS

Design of pH-sensitive polymer-modified liposomes for antigen delivery and their application in cancer immunotherapy

(2016) Eiji Yuba   POLYMER JOURNAL

Innate Immune Pattern Recognition: A Cell Biological Perspective

(2015) Sky W. Brubaker et al.   Annual Review of Immunology

Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice

(2015) Haniyeh Ghaffari-Nazari et al.   PLoS One

P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer

(2014) Sheida Shariat et al.   CANCER LETTERS

Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN

(2014) Mercedeh Mansourian et al.   IMMUNOLOGY LETTERS

Induction of protection against leishmaniasis in susceptible BALB/c mice using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA)

(2013) Hengameh Firouzmand et al.   ACTA TROPICA

Cancer Immunotherapy

(2013) J. Couzin-Frankel   SCIENCE

Liposomes containing monophosphoryl lipid A: A potent adjuvant system for inducing antibodies to heroin hapten analogs

(2013) Gary R. Matyas et al.   VACCINE

The role of liposome size on the type of immune response induced in BALB/c mice against leishmaniasis: rgp63 as a model antigen

(2012) Ali Badiee et al.   EXPERIMENTAL PARASITOLOGY

Effect of the Poly(ethylene glycol) (PEG) Density on the Access and Uptake of Particles by Antigen-Presenting Cells (APCs) after Subcutaneous Administration

(2012) Xi Zhan et al.   MOLECULAR PHARMACEUTICS

Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens

(2012) Douglas S. Watson et al.   VACCINE

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy

(2012) Erika Vacchelli et al.   OncoImmunology

Induction of tumor-specific immunity by multi-epitope rat HER2/neu-derived peptides encapsulated in LPD Nanoparticles

(2011) Seyed Amir Jalali et al.   Nanomedicine-Nanotechnology Biology and Medicine

Immunotherapy of cancer

(2009) Hossein Borghaei et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators

(2009) Pernille Nordly et al.   Expert Opinion on Drug Delivery

Putting endotoxin to work for us: Monophosphoryl lipid A as a safe and effective vaccine adjuvant

(2008) C. R. Casella et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Endocytosis mechanisms and the cell biology of antigen presentation

(2008) Sven Burgdorf et al.   CURRENT OPINION IN IMMUNOLOGY